Vienna, Austria

Gerhild Zauner

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gerhild Zauner: Innovator in Medical Antibody Development

Introduction

Gerhild Zauner is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the development of antibodies for multi-drug resistant strains of bacteria. With a total of 5 patents, her work has the potential to impact diagnostics and treatment options in healthcare.

Latest Patents

One of her latest patents is titled MDRimmunogen. This invention relates to an isolated antibody that specifically binds to the O25b antigen of multi-drug resistant (MDR) strains. The patent outlines its medical and diagnostic use, as well as the method of producing the antibody. This includes an isolated nucleotide sequence, plasmids, and host cells used in the production of the antibody. Additionally, it describes an isolated epitope recognized by the specific antibody.

Career Highlights

Throughout her career, Gerhild Zauner has worked with notable companies such as Arsanis Biosciences GmbH and Janssen Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the field of immunology.

Collaborations

Gerhild has collaborated with several talented individuals, including Eszter Nagy and Valéria Szijárto. These partnerships have fostered innovation and have been instrumental in advancing her research projects.

Conclusion

Gerhild Zauner's work in the development of antibodies for multi-drug resistant strains showcases her dedication to improving medical diagnostics and treatments. Her innovative contributions continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…